Your location:Home page > Program
Search:
All Dates:
  • All
  • 2026-06-11 [Thursday]
  • 2026-06-12 [Friday]
  • 2026-06-13 [Saturday]
  • 2026-06-14 [Sunday]
All Rooms:
  • All
  • A1-A (102-107)
  • A1-A101
  • A1-A102
  • A1-A103
  • A1-A104
  • A1-A (105-107)
  • A1-A108
  • A1-A109
  • A1-A110
  • A2-A207
  • A2-A208
  • A1-A213
  • A1-A214
  • A1-A215
  • B1 Hall (Poster Area)
  • B1 Hall (Exhibition Area)

2026-06-14 (Sunday)

A1-A108

08:00-09:30 | Oral Presentation 23
NO. Time Presentation Topic Speaker Affiliation / Organization
1 08:00-08:06

Chemotherapy plus concurrent irreversible electroporation improved local tumor control in unresectable hilar cholangiocarcinoma compared with chemotherapy alone

Yang-Yang Ma Fuda Cancer Hospital, China
2 08:08-08:14

Efficacy of cryoablation combined with sorafenib for the treatment of advanced renal cell carcinoma

Yu-Qing Xu Tianjin Medical University Cancer Institute & Hospital, China
3 08:16-08:22

Radioactive iodine-125 particle implantation combined with transarterial chemoinfusion and synchronous immune checkpoint inhibitors for the management of locally advanced pancreatic cancer: a retrospective single-center analysis

Bin Li Beijing Hospital, China
4 08:24-08:30

Antegrade DJ Stenting in Obstructive Ureteric Calculus After Failed Retrograde Access: A Radiology-Driven Management Approach

Md Alauddin Saddam Interventional Radiology, Bangladesh
5 08:40-08:46

Liquid glue or solid particles? Randomized trial comparing embolic agents for bronchial artery embolization in patients with haemoptysis.

Vineeth Kurki Manjunath Narayana Health City, India
6 08:48-08:54

The role of interventional radiology methods in the treatment of portal hypertension in Kazakhstan. Single-center study.

Niyaz Malayev National Scientific Medical Center, Kazakhstan
7 08:56-09:02

When Injury Meets Disease: Endovascular Stenting of Traumatic versus Atherosclerotic Celiac Artery Dissection

Jayson Naguit Philippine Society of Vascular and Interventional Radiology, Philippines
8 09:12-09:18

ENDOVASCULAR TREATMENT FOR MANAGEMENT SPLANCHNIC CIRCULATION ANEURYSM: EXPERIENCE AT CHO RAY HOSPITAL

Bao Van Tien Nguyen Cho Ray Hospital, Ho Chi Minh City, Vietnam
09:30-10:00 | Break / Poster Presentation
10:00-11:30 | Oral Presentation 25
NO. Time Presentation Topic Speaker Affiliation / Organization
1 10:08-10:14

Immune microenvironment remodeling in patients with unresectable hepatocellular carcinoma pre- versus post- transarterial chemoembolization combined with tyrosine kinase inhibitors and immune checkpoint inhibitors: insights from single-cell transcriptomic profiling

Hai-Feng Zhou Jiangsu Province Hospital (The First Affilated Hospital with Nanjing Medical University), China
2 10:16-10:22

Clinical efficacy of HAIC (RALOX) combined with systemic therapy vs. TACE combined with systemic therapy in the treatment of advanced hepatocellular carcinoma with arterioportal fistulas

Ru-Jian Wang The Affiliated Yantai Yuhuangding Hospital of Qingdao University, China
3 10:24-10:30

Two Cases of Hepatocellular Carcinoma Rupture Following Transarterial Chemoembolization with Radiopaque Small-caliber Drug-eluting Microspheres

Xin-Ran Guo Chengdu Medical College, China
4 10:32-10:38

Efficacy, Survival, and Cost-effectiveness Associated With cTACE vs DEB-TACE for Treatment of Solitary Large HCC: A Propensity-Matched Study

Mu Ding Binzhou Medical University Hospital, China
5 10:48-10:54

Prediction of overall survival in unresectable HCC receiving TACE plus atezolizumab and bevacizumab: A multicenter retrospective study

Li-Wei Deng The Cancer Institute and Hospital, Chinese Academy of Medical Sciences (CAMS), China
6 10:56-11:02

Multiscale Intra- and Peritumoral MRI Radiomics Combined with Pathological Spatial Heterogeneity for Recurrence Prediction in Hepatocellular Carcinoma After Resection and Adjuvant TACE

Chun-Li Kong The Fifth Affiliated Hospital of Wenzhou Medical University, China
7 11:04-11:10

Efficacy and Safety of TACE With or Without MWA Followed by Sequential Targeted and Immunotherapy in HCC Beyond the UP-to-7 Criteria

Yang Fang The Affiliated Hospital of Yanbian University Yanbian Hospital, China